Medical - Pharmaceuticals
The companies in this industry manufacture and process pharmaceutical products in the treatment of health disorders and illnesses. Demand for pharmaceuticals is driven by the desire to cure illness and disease. The profitability of individual companies depends on their ability to discover and market new drugs.
Share This Page
Industry Rating
Loading, please wait...
Rk | Symbol | Name | Last | Day
Chg
| Mkt
Cap
| POWR
|
---|---|---|---|---|---|---|
1 | NVS | Novartis AG ADR | 112.14 | 0.97 (0.87%) | 236.89B | A |
2 | ESAIY | Eisai Co. Ltd. ADR | 7.08 | -0.04 (-0.56%) | N/A | A |
3 | RHHBY | Roche Holding AG ADR | 39.52 | -0.23 (-0.58%) | 252.06B | A |
4 | TARO | Taro Pharmaceutical Industries Ltd. | 42.97 | 0.00 (0.00%) | 1.62B | NR |
5 | JNJ | Johnson & Johnson | 154.58 | -0.35 (-0.23%) | 371.93B | A |
6 | AZN | AstraZeneca PLC ADR | 69.57 | 0.02 (0.03%) | 215.75B | A |
7 | BMY | Bristol-Myers Squibb Co. | 47.90 | -0.79 (-1.62%) | 97.47B | A |
8 | SNPHY | SANTEN PHARMACEUTICAL CO., LTD. | 9.81 | 0.24 (2.46%) | N/A | A |
9 | CPRX | Catalyst Pharmaceuticals, Inc. | 23.45 | 0.26 (1.12%) | 2.86B | A |
10 | SUPN | Supernus Pharmaceuticals, Inc. | 32.22 | 0.87 (2.78%) | 1.80B | A |
11 | GSK | GSK PLC ADR | 37.43 | -0.07 (-0.19%) | 77.23B | A |
12 | HZNP | Horizon Therapeutics PLC | 116.30 | 0.05 (0.04%) | 26.63B | NR |
13 | AUPH | Aurinia Pharmaceuticals Inc | 8.18 | 0.08 (0.99%) | 1.12B | A |
14 | NVO | Novo Nordisk A/S ADR | 62.08 | -0.55 (-0.88%) | 278.59B | A |
15 | CALT | Calliditas Therapeutics AB ADR | 40.00 | -0.16 (-0.40%) | 1.19B | A |
16 | ALPMY | Astellas Pharma Inc. ADR | 10.07 | 0.50 (5.22%) | 18.22B | B |
17 | IPSEY | Ipsen S.A. | 27.90 | -0.54 (-1.90%) | 9.35B | B |
18 | BTMD | Biote Corp. | 3.43 | -0.02 (-0.58%) | 187.66M | B |
19 | NBIX | Neurocrine Biosciences, Inc. | 106.73 | 0.97 (0.92%) | 10.56B | B |
20 | KMDA | Kamada Ltd. | 6.69 | 0.07 (1.06%) | 384.54M | B |
21 | AMRX | Amneal Pharmaceuticals, Inc. | 7.48 | 0.06 (0.81%) | 2.32B | B |
22 | SNY | Sanofi - ADR | 52.32 | -1.22 (-2.28%) | 132.17B | B |
23 | RIGL | Rigel Pharmaceuticals, Inc. | 19.28 | 0.22 (1.15%) | 344.48M | B |
24 | ABBV | AbbVie Inc. | 186.06 | 5.69 (3.15%) | 329.14B | B |
25 | MRK | Merck & Co. Inc. | 82.74 | 2.90 (3.63%) | 208.65B | B |
26 | DSNKY | Daiichi Sankyo Company, Limited | 24.85 | 1.35 (5.74%) | 47.42B | B |
27 | PCRX | Pacira BioSciences, Inc. | 25.72 | -0.28 (-1.08%) | 1.19B | B |
28 | CPIX | Cumberland Pharmaceuticals Inc. | 4.97 | 0.13 (2.69%) | 69.42M | B |
29 | COLL | Collegium Pharmaceutical, Inc. | 26.79 | 0.01 (0.04%) | 860.82M | B |
30 | HLUYY | H. Lundbeck A/S | 22.00 | -0.01 (-0.02%) | 21.91B | NR |
31 | CRLBF | Cresco Labs Inc. | 0.84 | 0.06 (8.14%) | 414.17M | B |
32 | PROC | Procaps Group, S.A. | 1.01 | -0.58 (-36.51%) | 113.95M | NR |
33 | GDRX | GoodRx Holdings, Inc. | 4.68 | -0.12 (-2.50%) | 1.80B | B |
34 | ACAD | ACADIA Pharmaceuticals Inc. | 14.73 | -0.10 (-0.67%) | 2.46B | B |
35 | HLN | Haleon PLC ADR | 10.18 | -0.01 (-0.10%) | 45.95B | B |
36 | MEIP | MEI Pharma, Inc. | 2.10 | -0.06 (-2.78%) | 13.99M | B |
37 | KPRX | Kiora Pharmaceuticals Inc. | 3.20 | 0.00 (0.00%) | 9.60M | B |
38 | XERS | Xeris Pharmaceuticals, Inc. | 4.31 | 0.03 (0.70%) | 674.02M | B |
39 | PSTX | Poseida Therapeutics Inc. | 9.50 | -0.06 (-0.63%) | 928.85M | B |
40 | LLY | Eli Lilly & Co. | 884.54 | 24.81 (2.89%) | 838.69B | B |
41 | OPHLY | ONO PHARMACEUTICAL CO., LTD. | 3.72 | -0.14 (-3.50%) | N/A | B |
42 | ZTS | Zoetis Inc. | 153.47 | 1.17 (0.77%) | 68.48B | B |
43 | JUSHF | Jushi Holdings Inc. | 0.34 | -0.01 (-2.24%) | 66.97M | B |
44 | PFE | Pfizer Inc. | 22.92 | 0.14 (0.61%) | 129.99B | B |
45 | WXXWY | WuXi Biologics (Cayman) Inc. | 5.80 | -0.13 (-2.16%) | N/A | B |
46 | ASRT | Assertio Therapeutics, Inc. | 0.62 | -0.01 (-1.89%) | 59.19M | B |
47 | SNOA | Sonoma Pharmaceuticals, Inc. | 4.23 | 0.37 (9.59%) | 6.84M | B |
48 | BAYRY | Bayer AG ADR | 6.61 | 0.18 (2.80%) | 25.98B | B |
49 | ACIU | AC Immune SA | 1.64 | -0.02 (-1.20%) | 164.67M | B |
50 | TEVA | Teva Pharmaceutical Industries Ltd. ADR | 14.87 | 0.15 (1.02%) | 16.86B | B |
51 | FENC | Fennec Pharmaceuticals Inc. | 5.63 | -0.06 (-1.05%) | 155.35M | B |
52 | CLLS | Cellectis S.A. | 1.53 | 0.02 (1.32%) | 85.04M | B |
53 | BHC | Bausch Health Companies Inc. | 5.44 | -0.04 (-0.73%) | 2.01B | B |
54 | ESALY | Eisai Co. Ltd. ADR | 61.51 | -1.33 (-2.11%) | 17.64B | NR |
55 | AERI | Aerie Pharmaceuticals, Inc. | 15.25 | 0.01 (0.07%) | 753.61M | NR |
56 | GTBIF | Green Thumb Industries Inc. | 5.92 | -0.27 (-4.36%) | 1.26B | C |
57 | KNSA | Kiniksa Pharmaceuticals, Ltd. - | 21.36 | 0.81 (3.92%) | 1.55B | C |
58 | PRGO | Perrigo Co. PLC | 25.22 | 0.33 (1.33%) | 3.44B | C |
59 | IRWD | Ironwood Pharmaceuticals, Inc. - | 0.89 | 0.01 (1.12%) | 143.77M | C |
60 | CTMX | CytomX Therapeutics, Inc. | 0.71 | -0.06 (-7.29%) | 56.87M | C |
61 | EOLS | Evolus, Inc. | 11.65 | 0.10 (0.87%) | 740.79M | C |
62 | TCNNF | Trulieve Cannabis Corp. | 4.47 | -0.20 (-4.28%) | N/A | C |
63 | TAK | Takeda Pharmaceutical Co. Ltd. ADR | 15.03 | -0.08 (-0.53%) | 47.82B | C |
64 | GBIO | Generation Bio Inc. | 0.43 | 0.01 (1.55%) | 28.62M | C |
65 | ELAN | Elanco Animal Health Incorporated | 9.46 | 0.00 (0.00%) | 4.70B | C |
66 | SLGL | Sol-Gel Technologies Ltd. | 0.78 | 0.01 (0.80%) | 21.79M | NR |
67 | RDY | Dr. Reddy's Laboratories Ltd | 13.79 | -0.21 (-1.50%) | 11.51B | C |
68 | ENDP | Endo International PLC | 0.29 | -0.02 (-5.00%) | 68.80M | NR |
69 | PTGX | Protagonist Therapeutics, Inc. | 44.49 | -0.36 (-0.80%) | 2.73B | C |
70 | APLS | Apellis Pharmaceuticals, Inc. | 17.49 | -0.05 (-0.29%) | 2.20B | C |
71 | GRFS | Grifols, S.A. | 7.21 | 0.03 (0.42%) | 4.96B | C |
72 | EGRX | Eagle Pharmaceuticals, Inc. | 1.70 | 0.20 (13.33%) | 22.08M | C |
73 | WVE | Wave Life Sciences Ltd. - Ordinary Shares | 6.73 | -0.06 (-0.88%) | 1.03B | C |
74 | ADMS | Adamas Pharmaceuticals, Inc. | 8.22 | 0.06 (0.74%) | 376.37M | NR |
75 | ASMB | Assembly Biosciences, Inc. | 10.70 | 0.17 (1.61%) | 81.73M | C |
76 | AVDL | Avadel Pharmaceuticals plc each representing one Ordinary Share | 8.77 | 0.17 (1.98%) | 847.44M | C |
77 | LZAGY | Lonza Group AG ADR | 69.47 | 0.57 (0.83%) | 50.18B | C |
78 | ARVN | Arvinas, Inc. | 9.05 | -0.09 (-0.98%) | 622.39M | C |
79 | AMPH | Amphastar Pharmaceuticals, Inc. | 24.19 | 0.12 (0.50%) | 1.15B | C |
80 | KPTI | Karyopharm Therapeutics Inc. | 5.62 | -0.35 (-5.86%) | 48.16M | C |
81 | EVTCY | Evotec SE | 22.96 | -0.01 (-0.04%) | 7.58B | NR |
82 | SURF | Surface Oncology, Inc. | 1.07 | -0.01 (-0.93%) | 65.08M | NR |
83 | VTRS | Viatris Inc. | 8.13 | 0.10 (1.25%) | 9.70B | C |
84 | SMTI | Sanara MedTech Inc. | 31.72 | -0.27 (-0.84%) | 281.93M | C |
85 | MGTA | Magenta Therapeutics, Inc. | 0.70 | -0.06 (-7.74%) | 42.44M | NR |
86 | HYPMY | Hypera S.A. | 4.21 | 0.06 (1.33%) | 2.66B | C |
87 | AXSM | Axsome Therapeutics, Inc. | 106.27 | 0.86 (0.82%) | 5.18B | C |
88 | CCHWF | Columbia Care Inc. | 0.94 | -0.20 (-17.25%) | N/A | NR |
89 | OGN | Organon & Co. | 12.20 | 0.08 (0.66%) | 3.15B | C |
90 | STRO | Sutro Biopharma, Inc. | 0.90 | -0.40 (-30.57%) | 76.15M | C |
91 | PTPI | Petros Pharmaceuticals Inc. | 0.05 | 0.00 (5.47%) | 2.89M | C |
92 | CWBHF | Charlotte's Web Holdings, Inc. | 0.08 | -0.00 (-5.14%) | N/A | NR |
93 | IMAB | I-Mab ADR | 0.84 | -0.01 (-1.51%) | 68.41M | C |
94 | MTEM | Molecular Templates, Inc. | 0.00 | 0.00 (0.00%) | 0.66K | NR |
95 | LPCN | Lipocine Inc. | 3.19 | 0.01 (0.31%) | 17.07M | C |
96 | OSMT | Osmotica Pharmaceuticals plc - Ordinary Shares | 1.11 | -0.02 (-1.77%) | 69.47M | NR |
97 | HOOK | HOOKIPA Pharma Inc. | 0.85 | 0.01 (1.18%) | 10.25M | C |
98 | CUE | Cue Biopharma, Inc. | 0.79 | -0.07 (-8.35%) | 48.53M | C |
99 | BFRA | Biofrontera AG | 2.67 | -0.28 (-9.49%) | 75.72M | NR |
100 | ALIM | Alimera Sciences, Inc. | 5.54 | -0.01 (-0.18%) | 290.24M | C |
101 | OPTN | OptiNose, Inc. | 9.28 | 0.02 (0.22%) | 93.98M | C |
102 | GRVI | GROVE, INC. | 4.95 | 0.35 (7.61%) | 83.26M | NR |
103 | SYBX | Synlogic, Inc. | 1.16 | 0.00 (0.34%) | 13.61M | C |
104 | ELOX | Eloxx Pharmaceuticals, Inc. | 0.00 | 0.00 (0.00%) | 0.31K | NR |
105 | NEOS | Neos Therapeutics, Inc. | 1.15 | -0.03 (-2.54%) | 57.22M | NR |
106 | ABEO | Abeona Therapeutics Inc. | 5.33 | -0.06 (-1.11%) | 260.10M | C |
107 | SPRO | Spero Therapeutics, Inc. | 0.73 | 0.00 (0.03%) | 40.54M | C |
108 | MGTX | MeiraGTx Holdings plc - Ordinary Shares | 6.70 | 0.15 (2.29%) | 528.33M | C |
109 | TXMD | TherapeuticsMD, Inc. | 1.15 | 0.01 (0.88%) | 13.31M | NR |
110 | PRLD | Prelude Therapeutics Inc. | 0.90 | 0.04 (4.56%) | 50.86M | C |
111 | RDHL | Redhill Biopharma Ltd. | 2.41 | 0.09 (3.88%) | 4.26M | C |
112 | BVXV | BiondVax Pharmaceuticals Ltd. | 1.36 | 0.05 (3.82%) | 2.54M | NR |
113 | TCDA | Tricida, Inc. | 0.11 | -0.01 (-10.00%) | 6.01M | NR |
114 | ETON | Eton Pharmaceuticals, Inc. | 15.82 | 0.03 (0.19%) | 424.26M | C |
115 | HAPP | HAPPINESS BIOTECH GROUP LTD | 4.50 | 0.06 (1.35%) | 31.30M | NR |
116 | BFRI | Biofrontera Inc. | 0.81 | -0.02 (-2.35%) | 7.45M | C |
117 | VRNOF | Verano Holdings Corp. | 0.82 | 0.08 (10.27%) | 292.90M | C |
118 | VYGR | Voyager Therapeutics, Inc. | 3.47 | -0.06 (-1.70%) | 191.94M | C |
119 | RMTI | Rockwell Medical, Inc. | 1.17 | -0.02 (-1.68%) | 39.98M | C |
120 | MTCR | Metacrine Inc. | 0.58 | -0.01 (-1.29%) | 24.75M | NR |
121 | ARCT | Arcturus Therapeutics Holdings Inc. | 12.91 | 0.02 (0.16%) | 350.12M | C |
122 | MYOV | Myovant Sciences Ltd. Common Shares | 26.98 | -0.01 (-0.04%) | 2.62B | NR |
123 | APNHY | Aspen Pharmacare Holdings Limited | 6.38 | 0.06 (0.95%) | 2.85B | C |
124 | IVA | Inventiva S.A. ADR | 3.89 | 0.12 (3.18%) | 204.14M | C |
125 | HROW | Harrow Health, Inc. | 25.55 | 0.48 (1.91%) | 910.96M | C |
126 | PYPD | PolyPid Ltd. | 2.60 | -0.07 (-2.44%) | 26.50M | NR |
127 | ZGNX | Zogenix, Inc. | 26.68 | 0.42 (1.60%) | 1.50B | NR |
128 | NVCR | Novocure Ltd. | 18.50 | -0.05 (-0.27%) | 2.06B | C |
129 | ORTX | Orchard Therapeutics plc | 16.70 | 0.05 (0.30%) | 380.11M | NR |
130 | ERYP | Erytech Pharma S.A. | 0.78 | 0.00 (0.00%) | 26.61M | NR |
131 | CURLF | Curaleaf Holdings, Inc. | 0.95 | -0.02 (-1.88%) | 632.08M | C |
132 | CNTA | Centessa Pharmaceuticals Limited | 13.79 | 0.18 (1.32%) | 1.84B | C |
133 | SBBP | Strongbridge Biopharma plc - Ordinary Shares | 2.00 | 0.03 (1.52%) | 135.66M | NR |
134 | SMMT | Summit Therapeutics plc | 23.47 | -13.24 (-36.06%) | 17.31B | C |
135 | VRCA | Verrica Pharmaceuticals Inc. | 0.49 | 0.02 (4.84%) | 45.22M | C |
136 | MIRM | Mirum Pharmaceuticals, Inc. - common stock | 40.80 | 0.33 (0.82%) | 2.02B | C |
137 | ITRM | Iterum Therapeutics plc - Ordinary Share | 1.26 | -0.04 (-3.08%) | 43.57M | C |
138 | NBRV | Nabriva Therapeutics plc - Ordinary Shares | 1.42 | 0.00 (0.00%) | 45.46M | NR |
139 | IMCC | IM Cannabis Corp. | 1.42 | -0.11 (-7.19%) | 3.17M | C |
140 | ODT | Odonate Therapeutics, Inc. | 1.12 | -0.05 (-4.27%) | 43.11M | NR |
141 | RPTX | Repare Therapeutics Inc. | 1.25 | -0.08 (-6.02%) | 53.14M | C |
142 | SNDL | Sundial Growers Inc. | 1.49 | 0.01 (0.68%) | 391.54M | C |
143 | LCI | Lannett Co Inc | 0.69 | 0.03 (3.86%) | 7.38M | NR |
144 | UROV | Urovant Sciences Ltd. | 16.24 | 0.01 (0.06%) | 531.75M | NR |
145 | AYRWF | Ayr Strategies Inc. | 0.23 | 0.01 (3.79%) | 26.72M | C |
146 | ECOR | electroCore, Inc. | 7.57 | 0.02 (0.26%) | 54.45M | C |
147 | YCBD | cbdMD Inc. | 0.26 | 0.01 (3.10%) | 1.65M | C |
148 | FLXN | Flexion Therapeutics, Inc. | 9.12 | -0.02 (-0.22%) | 458.93M | NR |
149 | CRXT | Clarus Therapeutics Holdings, Inc. | 0.05 | -0.02 (-31.16%) | 2.47M | NR |
150 | MOR | MorphoSys AG | 18.96 | 0.45 (2.43%) | 2.86B | C |
151 | RYTM | Rhythm Pharmaceuticals, Inc. | 63.76 | 0.79 (1.25%) | 4.03B | C |
152 | MIST | Milestone Pharmaceuticals Inc. | 1.28 | 0.02 (1.59%) | 68.29M | C |
153 | CVSI | CV Sciences, Inc. | 0.03 | 0.00 (1.79%) | 5.27M | NR |
154 | CTLT | Catalent Inc. | 63.48 | 0.00 (0.00%) | 11.52B | C |
155 | BYSI | BeyondSpring, Inc. - Ordinary Shares | 1.60 | -0.04 (-2.48%) | 64.51M | C |
156 | CLSD | Clearside Biomedical, Inc. | 0.84 | -0.01 (-0.80%) | 65.05M | C |
157 | ACB | Aurora Cannabis Inc. | 4.81 | 0.10 (2.12%) | 270.39M | C |
158 | SCYX | SCYNEXIS, Inc. | 1.02 | -0.05 (-4.23%) | 39.76M | C |
159 | HUGE | FSD Pharma Inc. | 0.09 | -0.01 (-10.10%) | 3.61M | NR |
160 | LHSIF | Liberty Health Sciences Inc. | 1.14 | -0.03 (-2.17%) | 392.01M | NR |
161 | TKNO | Alpha Teknova, Inc. | 6.49 | -0.16 (-2.41%) | 346.81M | D |
162 | YMAB | Y-mAbs Therapeutics, Inc. | 4.10 | -0.03 (-0.73%) | 185.39M | D |
163 | FIXX | Homology Medicines, Inc. | 0.93 | 0.01 (0.77%) | 54.34M | D |
164 | FFNTF | 4Front Ventures Corp. | 0.00 | 0.00 (25.00%) | N/A | NR |
165 | VBLT | Vascular Biogenics Ltd. - Ordinary Shares | 0.16 | -0.02 (-8.77%) | 12.11M | NR |
166 | LSDI | Lucy Scientific Discovery Inc. | 0.51 | -0.16 (-23.29%) | 907.03K | NR |
167 | ETTX | Entasis Therapeutics Holdings Inc. | 2.19 | -0.01 (-0.45%) | 104.80M | NR |
168 | SYRS | Syros Pharmaceuticals, Inc. - common stock | 0.03 | -0.01 (-17.31%) | 858.62K | D |
169 | EPIX | ESSA Pharma Inc. | 1.77 | -0.03 (-1.67%) | 78.57M | D |
170 | TRSSF | TerrAscend Corp. | 1.72 | 0.00 (0.00%) | 433.20M | NR |
171 | MLYS | Mineralys Therapeutics Inc. | 13.34 | -0.75 (-5.32%) | 865.45M | D |
172 | ALXO | ALX Oncology Holdings Inc. | 0.54 | -0.06 (-9.87%) | 28.92M | D |
173 | CHMA | Chiasma, Inc. | 3.76 | -0.24 (-6.00%) | 217.68M | NR |
174 | KALV | KalVista Pharmaceuticals, Inc. | 12.99 | 0.11 (0.85%) | 645.81M | D |
175 | RLAY | Relay Therapeutics Inc. | 3.20 | 0.01 (0.31%) | 542.47M | D |
176 | ATNX | Athenex, Inc. | 0.20 | -0.06 (-23.39%) | 1.76M | NR |
177 | APTX | Aptinyx Inc. | 0.10 | 0.00 (3.11%) | 6.50M | NR |
178 | SLRX | Salarius Pharmaceuticals Inc | 0.73 | 0.01 (1.85%) | 1.56M | D |
179 | NOVN | Novan, Inc. | 0.09 | -0.03 (-24.84%) | 2.64M | NR |
180 | SXTC | China SXT Pharmaceuticals, Inc. | 2.29 | 0.71 (44.94%) | 1.66M | D |
181 | TERN | Terns Pharmaceuticals, Inc. | 2.92 | -0.13 (-4.26%) | 254.91M | D |
182 | ACRHF | Acreage Holdings, Inc. | 0.00 | -0.00 (-2.44%) | N/A | NR |
183 | MMNFF | MedMen Enterprises Inc. | 0.00 | 0.00 (0.00%) | N/A | NR |
184 | OPNT | Opiant Pharmaceuticals, Inc. | 20.65 | -0.12 (-0.58%) | 106.64M | NR |
185 | MDGL | Madrigal Pharmaceuticals, Inc. | 326.79 | 6.86 (2.14%) | 7.22B | D |
186 | NVCT | Nuvectis Pharma Inc. | 10.49 | -0.47 (-4.29%) | 245.38M | D |
187 | VTVT | vTv Therapeutics Inc. - | 22.23 | -0.27 (-1.20%) | 70.91M | D |
188 | ITOS | iTeos Therapeutics Inc. | 7.35 | -0.11 (-1.47%) | 280.73M | D |
189 | TYME | Tyme Technologies, Inc. | 0.31 | 0.02 (8.07%) | 53.50M | NR |
190 | MESO | Mesoblast Limited | 11.82 | -0.04 (-0.34%) | 1.50B | D |
191 | PHAS | PhaseBio Pharmaceuticals, Inc. | 0.07 | -0.02 (-26.21%) | 3.50M | NR |
192 | NTEC | Intec Pharma Ltd. - Ordinary Shares | 9.63 | -1.37 (-12.48%) | 8.65M | NR |
193 | RDUS | Radius Health, Inc. | 29.24 | 0.05 (0.17%) | 824.63M | D |
194 | AGRX | Agile Therapeutics, Inc. | 1.51 | 0.00 (0.00%) | 10.35M | D |
195 | HRVSF | Harvest Health & Recreation Inc. | 3.22 | 0.03 (0.94%) | N/A | NR |
196 | APM | Aptorum Group Limited - Class A Ordinary Shares | 0.97 | -0.03 (-3.00%) | 5.03M | D |
197 | TRVI | Trevi Therapeutics, Inc. | 6.47 | 0.12 (1.89%) | 625.53M | D |
198 | EVOK | Evoke Pharma, Inc. | 2.58 | -0.01 (-0.39%) | 3.85M | NR |
199 | CRNX | Crinetics Pharmaceuticals, Inc. | 32.39 | -1.00 (-2.99%) | 3.03B | D |
200 | TENX | Tenax Therapeutics, Inc. | 5.80 | 0.03 (0.52%) | 24.06M | D |
201 | DNLI | Denali Therapeutics Inc. | 15.68 | 0.19 (1.23%) | 2.28B | D |
202 | OGI | OrganiGram Holdings Inc. | 1.16 | 0.00 (0.00%) | 146.48M | D |
203 | DRRX | DURECT Corporation | 0.67 | -0.03 (-4.34%) | 20.79M | D |
204 | SCPH | scPharmaceuticals Inc. | 2.51 | 0.01 (0.40%) | 126.21M | D |
205 | SVRA | Savara, Inc. | 3.18 | -0.09 (-2.75%) | 548.97M | D |
206 | NTRB | Nutriband Inc. | 5.32 | 0.00 (0.00%) | 59.08M | D |
207 | HEXO | HEXO Corp. | 0.71 | 0.02 (2.45%) | 31.24M | NR |
208 | KALA | Kala Pharmaceuticals, Inc. | 3.18 | -0.12 (-3.64%) | 20.52M | D |
209 | NYMX | Nymox Pharmaceutical Corporation | 0.20 | -0.05 (-19.68%) | 18.10M | NR |
210 | BKUH | Bakhu Holdings, Corp. | 0.02 | -0.49 (-97.00%) | N/A | NR |
211 | ALLO | Allogene Therapeutics, Inc. | 1.55 | -0.02 (-1.27%) | 336.76M | D |
212 | CMPI | Checkmate Pharmaceuticals Inc. | 10.50 | 0.02 (0.19%) | 231.40M | NR |
213 | ACRX | AcelRx Pharmaceuticals, Inc. | 0.86 | 0.06 (7.50%) | 14.58M | NR |
214 | BBIO | BridgeBio Pharma, Inc. | 36.31 | 0.35 (0.96%) | 6.89B | D |
215 | SBFM | Sunshine Biopharma Inc. | 1.51 | -0.04 (-2.58%) | 4.09M | D |
216 | GLSI | Greenwich LifeSciences Inc. | 9.98 | -0.46 (-4.41%) | 132.47M | D |
217 | CLDI | Calidi Biotherapeutics Inc. | 0.48 | -0.01 (-2.88%) | 13.75M | D |
218 | ACRS | Aclaris Therapeutics, Inc. | 1.34 | 0.07 (5.51%) | 145.10M | D |
219 | ALBO | Albireo Pharma, Inc. | 44.15 | -0.10 (-0.23%) | 913.95M | NR |
220 | APLT | Applied Therapeutics, Inc. | 0.40 | 0.00 (0.10%) | 56.45M | D |
221 | CMPS | COMPASS Pathways PLC ADR | 3.82 | -0.17 (-4.26%) | 354.01M | D |
222 | FUSN | Fusion Pharmaceuticals Inc. | 21.55 | 0.03 (0.14%) | 1.83B | D |
223 | RGC | Regencell Bioscience Holdings Ltd. | 29.01 | -0.41 (-1.39%) | 377.51M | D |
224 | REPL | Replimune Group, Inc. | 9.05 | -0.01 (-0.11%) | 696.99M | D |
225 | LQDA | Liquidia Technologies, Inc. | 14.12 | 0.09 (0.64%) | 1.20B | D |
226 | BTAI | BioXcel Therapeutics, Inc. | 1.87 | 0.02 (1.08%) | 10.26M | D |
227 | VERU | Veru Inc. | 0.54 | -0.01 (-2.02%) | 78.75M | D |
228 | ALNA | Allena Pharmaceuticals, Inc. | 0.08 | 0.00 (3.16%) | 9.16M | NR |
229 | RCEL | AVITA Medical, Inc. | 10.07 | 0.18 (1.82%) | 266.20M | D |
230 | GRAY | Graybug Vision Inc | 5.50 | -0.67 (-10.80%) | 8.64M | NR |
231 | ARDS | Aridis Pharmaceuticals Inc. | 0.00 | 0.00 (0.00%) | 5.33K | NR |
232 | LYRA | Lyra Therapeutics Inc. | 0.11 | 0.01 (5.95%) | 6.92M | D |
233 | ACER | Acer Therapeutics Inc. | 0.66 | -0.14 (-17.95%) | 16.15M | NR |
234 | CNSP | CNS PHARMACEUTICALS, INC. | 1.09 | 0.05 (4.81%) | 3.21M | D |
235 | RETA | Reata Pharmaceuticals, Inc. - | 172.36 | 0.04 (0.02%) | 6.58B | NR |
236 | ORGS | Orgenesis Inc. | 2.32 | 0.05 (1.98%) | 11.11M | D |
237 | IMRN | Immuron Limited | 1.79 | 0.07 (4.20%) | 10.47M | NR |
238 | HOTH | Hoth Therapeutics, Inc. | 0.86 | -0.00 (-0.36%) | 11.27M | D |
239 | ZYNE | Zynerba Pharmaceuticals, Inc. | 1.30 | 0.03 (2.36%) | 70.12M | NR |
240 | GRAL | GRAIL Inc. | 37.20 | -0.49 (-1.30%) | 1.31B | D |
241 | SNES | SenesTech, Inc. | 2.27 | 0.09 (4.13%) | 4.03M | D |
242 | JUVAF | Juva Life Inc. | 0.00 | 0.00 (0.00%) | N/A | NR |
243 | EYPT | EyePoint Pharmaceuticals, Inc. | 6.37 | -0.17 (-2.60%) | 437.80M | D |
244 | ATXI | Avenue Therapeutics, Inc. | 0.25 | 0.00 (0.76%) | 793.80K | D |
245 | ADIL | Adial Pharmaceuticals, Inc | 0.69 | -0.03 (-4.20%) | 4.50M | D |
246 | CKPT | Checkpoint Therapeutics, Inc. | 4.10 | 0.01 (0.24%) | 343.43M | D |
247 | SNGX | Soligenix, Inc. | 2.17 | 0.02 (0.70%) | 5.45M | D |
248 | IDYA | IDEAYA Biosciences, Inc. | 19.00 | -0.07 (-0.37%) | 1.66B | D |
249 | GPCR | Structure Therapeutics Inc. ADR | 23.74 | 0.09 (0.38%) | 1.36B | D |
250 | IONS | Ionis Pharmaceuticals, Inc. | 29.70 | 0.13 (0.44%) | 4.72B | D |
251 | ANVS | Annovis Bio Inc. | 1.57 | -0.07 (-4.27%) | 22.35M | D |
252 | VREOF | Vireo Health International, Inc. | 0.42 | 0.02 (4.87%) | 142.47M | NR |
253 | RFL | Rafael Holdings, Inc. Class B | 1.73 | 0.02 (1.17%) | 43.10M | NR |
254 | PCVX | Vaxcyte Inc. | 32.92 | -1.59 (-4.61%) | 4.24B | F |
255 | CNST | Constellation Pharmaceuticals, Inc. | 33.99 | 0.02 (0.06%) | 1.63B | NR |
256 | SNDX | Syndax Pharmaceuticals, Inc. | 13.33 | 0.03 (0.23%) | 1.15B | F |
257 | TLRY | Tilray Brands Inc. Cl 2 | 0.49 | -0.01 (-1.06%) | 490.26M | F |
258 | BGXX | Bright Green Corp. | 0.04 | -0.00 (-2.56%) | 7.26M | NR |
259 | ACST | Acasti Pharma, Inc. - | 3.37 | -0.03 (-0.88%) | 31.67M | NR |
260 | ZOM | Zomedica Corp. | 0.10 | -0.00 (-0.21%) | 95.35M | NR |
261 | EYEN | Eyenovia, Inc. | 1.09 | -0.04 (-3.54%) | 3.08M | F |
262 | CDMO | Avid Bioservices, Inc. | 12.49 | 0.01 (0.08%) | 798.90M | F |
263 | CGC | Canopy Growth Corporation | 1.41 | -0.08 (-5.37%) | 259.25M | F |
264 | NNOX | Nano-X Imaging Ltd. | 5.25 | -0.07 (-1.32%) | 303.34M | F |
265 | VKTX | Viking Therapeutics, Inc. | 24.99 | -0.67 (-2.61%) | 2.81B | F |
266 | CDT | Conduit Pharmaceuticals Inc. | 0.56 | 0.02 (4.07%) | 3.75M | F |
267 | RXRX | Recursion Pharmaceuticals Inc. | 5.73 | -0.02 (-0.35%) | 2.30B | F |
268 | SHOT | Safety Shot Inc. | 0.51 | 0.10 (25.93%) | 37.93M | F |
269 | PRFX | PainReform Ltd. | 2.35 | 0.03 (1.29%) | 2.06M | F |
NR | CBDHF | HempFusion Wellness Inc. | 0.00 | 0.00 (900.00%) | N/A | NR |
NR | KHRNF | Khiron Life Sciences Corp. | 0.00 | 0.00 (0.00%) | N/A | NR |
NR | ANTCF | Aion Therapeutic Inc. | 0.01 | 0.00 (0.00%) | N/A | NR |
NR | MJNA | Medical Marijuana Inc. | 0.00 | 0.00 (50.00%) | N/A | NR |
NR | GDTC | CytoMed Therapeutics Ltd. | 2.28 | -0.07 (-2.98%) | 24.94M | NR |
NR | ICNAF | Icanic Brands Company Inc. | 0.06 | 0.00 (0.00%) | N/A | NR |
NR | SLGWF | SLANG Worldwide Inc. | 0.00 | -0.00 (-24.39%) | N/A | NR |
NR | ACUR | Acura Pharmaceuticals | 0.02 | 0.00 (0.00%) | 1.32M | NR |
NR | TLC | Taiwan Liposome Company, Ltd. - ADRs | 7.00 | 0.00 (0.00%) | 294.54M | NR |
NR | ZEAL | Zealand Pharma A/S | 17.59 | 0.21 (1.21%) | 818.60M | NR |
NR | EIDX | Eidos Therapeutics, Inc. | 122.21 | -6.23 (-4.85%) | 4.75B | NR |
All price changes on this page include dividends and splits.